FP
FPMI.US Fluoropharma Medical
- Market cap
- USD 6.85K
- P/E
- -
- P/B
- 17.76x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2022.
Is FPMI.US undervalued?
Graham numberThe Graham number of Fluoropharma Medical cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Fluoropharma Medical fundamental analysis
No fundamental analysis for Fluoropharma Medical yet.
Fluoropharma Medical stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Fluoropharma Medical
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. The company was founded in 2003 and is headquartered in Montclair, New Jersey.
Full company profileFluoropharma Medical financial statements
Fluoropharma Medical annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | - | - | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - |
| Gross Profit | - | - | 0.00 | 0.00 | -46.4K | -43.9K | - | - | - | - |
| Operating Income | - | - | -4.23K | -5.17K | -3.19M | -2.20M | - | - | - | - |
| EBITDA | - | - | -5.53M | -3.98M | -2.24M | -744K | - | - | - | - |
| Net Income | - | - | -7.28K | -4.69K | -3.16M | -2.05M | - | - | - | - |
| EPS | - | - | 0.00 | 0.00 | -0.11 | -0.06 | - | - | - | - |
| Balance Sheet | ||||||||||
| Total Assets | 3.55M | 1.61M | 1.92M | 820K | 975K | 335K | - | - | - | - |
| Total Liabilities | 380K | 236K | 2.97M | 5.62M | 8.84M | 10.5M | - | - | - | - |
| Shareholders' Equity | 3.17M | 1.38M | -1.06M | -4.80M | -7.86M | -10.2M | - | - | - | - |
| Cash & Short-term Investments | 3.27M | 1.30M | 1.78M | 292K | 291K | 24.7K | - | - | - | - |
| Total Debt | - | - | - | 2.12M | 4.49M | 5.82M | - | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -2.28M | -3.28M | -3.33M | -3.32M | -2.68M | -880K | - | - | - | - |
| Capital Expenditure | 186K | 40.9K | 5.36K | 357K | 6.69K | 1.29K | - | - | - | - |
| Free Cash Flow | -2.47M | -3.32M | -3.34M | -3.68M | -2.68M | -881K | - | - | - | - |
| Ratios | ||||||||||
| ROA | - | - | -0.4% | -0.6% | -324.5% | -612.3% | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
Fluoropharma Medical dividends
Fluoropharma Medical has not paid dividends in the last 10 fiscal years.
Who owns Fluoropharma Medical
Ownership data of Fluoropharma Medical is not available yet.
Fluoropharma Medical company profile
- Company name
- Fluoropharma Medical
- Ticker
- FPMI.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 4
- Fiscal year end
- December
- Address
- 8 Hillside Avenue, Montclair, NJ, United States, 07042
- Phone
- 973-744-1565
- Website
- fluoropharma.com
About Fluoropharma Medical
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. The company was founded in 2003 and is headquartered in Montclair, New Jersey.
Fluoropharma Medical management
1- Mr. Edward L. Lyons Jr.Vice President of Development